ATRC Oct 2024 30.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
| Previous Close | 1.2000 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 30.00 |
| Expire Date | 2024-10-18 |
| Day's Range | 1.2000 - 1.2000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
GuruFocus.comInsider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC)
On May 30, 2024, Salvatore Privitera, Chief Technical Officer of AtriCure Inc (NASDAQ:ATRC), purchased 5,000 shares of the company, as reported in a recent SEC Filing.
Business WireAtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
MASON, Ohio, May 15, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Leerink Partners Healthcare Crossroads Conference.
Simply Wall St.AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target
Shareholders might have noticed that AtriCure, Inc. ( NASDAQ:ATRC ) filed its first-quarter result this time last week...
© 2024 Yahoo. All rights reserved.